NOVOGRID

Pharmaceuticals; implantable medicines; transplants [living tissues]; implants (surgical -) [living tissues]; implants comprising living tissue; implants for guided tissue regeneration; surgical implants grown from stem cells [living tissues]; processed human donor skin for the replacement of soft tissue; live organs and tissues for surgical purpose; human allograft tissue; skin grafts; vascular grafts [living tissue]; anti-adhesion gels for use with wound drainage devices; anti-adhesion barrier film for medical use; anti-adhesion barrier sheet for medical use; surgical plasters; wound dressings; impregnated pads containing medicated preparations; adhesive skin patches for medical use.

Medical apparatus and instruments; medical instruments; orthopaedic articles; surgical apparatus and instruments; medical apparatus and instruments for anti-adhesion; suture materials for medical purposes; endoprostheses; medical, surgical and orthopaedic implants made of artificial materials; bone void fillers comprised of artificial materials; prostheses for transplant surgery; artificial grafts for surgical use; surgical implants; artificial biomaterials for dermatology; artificial implants for skin regeneration; artificial skin for surgical purposes; implants for tissue anti-adhesion; implants [prosthesis] for use in bone grafting; implants for osteosynthesis; osseous implants; artificial bone parts to be implanted in natural bones.